Evogene Ltd. (EVGN)
0.3822
-0.02
(-4.09%)
USD |
NASDAQ |
Oct 09, 16:00
0.3907
+0.01
(+2.22%)
After-Hours: 20:00
Evogene Max Drawdown (5Y) : 99.05% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.05% |
| August 31, 2026 | 99.05% |
| July 31, 2026 | 99.05% |
| June 30, 2026 | 99.05% |
| May 31, 2026 | 99.05% |
| April 30, 2026 | 99.05% |
| March 31, 2026 | 99.05% |
| February 28, 2026 | 99.05% |
| January 31, 2026 | 99.05% |
| December 31, 2025 | 99.05% |
| November 30, 2025 | 99.02% |
| October 31, 2025 | 99.02% |
| September 30, 2025 | 99.02% |
| August 31, 2025 | 99.02% |
| July 31, 2025 | 99.02% |
| June 30, 2025 | 99.02% |
| May 31, 2025 | 99.02% |
| April 30, 2025 | 99.02% |
| March 31, 2025 | 98.75% |
| February 28, 2025 | 98.75% |
| January 31, 2025 | 98.75% |
| December 31, 2024 | 98.75% |
| November 30, 2024 | 98.39% |
| October 31, 2024 | 97.85% |
| September 30, 2024 | 97.47% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.69% |
| July 31, 2024 | 95.29% |
| June 30, 2024 | 95.29% |
| May 31, 2024 | 95.29% |
| April 30, 2024 | 95.29% |
| March 31, 2024 | 95.29% |
| February 29, 2024 | 95.29% |
| January 31, 2024 | 95.29% |
| December 31, 2023 | 95.29% |
| November 30, 2023 | 95.29% |
| October 31, 2023 | 95.29% |
| September 30, 2023 | 94.35% |
| August 31, 2023 | 94.35% |
| July 31, 2023 | 94.35% |
| June 30, 2023 | 94.35% |
| May 31, 2023 | 94.35% |
| April 30, 2023 | 94.27% |
| March 31, 2023 | 94.06% |
| February 28, 2023 | 93.86% |
| January 31, 2023 | 93.86% |
| December 31, 2022 | 93.86% |
| November 30, 2022 | 93.69% |
| October 31, 2022 | 93.16% |
| September 30, 2022 | 92.69% |
| August 31, 2022 | 92.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Compugen Ltd. | 97.28% |
| Pluri, Inc. | 96.65% |
| Scinai Immunotherapeutics Ltd. | 99.97% |
| CollPlant Biotechnologies Ltd. | 98.79% |
| Regentis Biomaterials Ltd. | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -74.99 |
| Beta (5Y) | 1.440 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 72.67% |
| Historical Sharpe Ratio (5Y) | -0.8337 |
| Historical Sortino (5Y) | -1.761 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.47% |